BOSTON, Mass., Nov. 2 /PRNewswire/ -- NMT Medical, Inc. announced today that it received the 2006 Medical Device Innovation Award in the Emerging Companies category for its STARFlex(R) septal repair implant from the Massachusetts Medical Device Industry Council (MassMEDIC). NMT’s senior management will accept the award at MassMEDIC’s 8th Annual MedTech Investors Conference, held in Boston on Thursday, November 9, at the Boston Park Plaza Hotel.
“We are honored that MassMEDIC has recognized our implant technology for its innovation,” said John E. Ahern, President and Chief Executive Officer of NMT. “We invested substantial resources in the research and development of our STARFlex(R) implant, which is used to treat structural heart disease through a catheter-based, minimally invasive procedure. I would like to extend our appreciation to MassMEDIC for acknowledging NMT’s efforts and also to the entire NMT team for this notable achievement.”
The MassMEDIC “Medical Device Innovation Award” is sponsored by NixonPeabody and Smith & Nephew. The awards honor novel Massachusetts-based medical technologies that have demonstrated a positive outcome in the healthcare setting. Awards are presented in three categories -- early-stage, emerging and established companies.
About NMT Medical, Inc.
NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT Medical is currently investigating the potential connection between a common cardiac defect called a PFO and brain attacks such as migraine headaches, stroke and transient ischemic attacks (TIAs). A PFO can allow venous blood, unfiltered and unmanaged by the lungs, to enter the arterial circulation of the brain, possibly triggering a cerebral event or brain attack. More than 21,000 PFOs have been treated globally with NMT’s minimally invasive, catheter-based implant technology. The prevalence of migraines in the United States is about 10%. Of the 28 million migraine sufferers in America, those who experience aura and have a PFO may represent a three million patient subset. Stroke is the third leading cause of death in the United States and the leading cause of disability in adults. Each year, 750,000 Americans suffer a new or recurrent stroke and an additional 500,000 Americans experience a TIA.
For more information about NMT Medical, please visit http://www.nmtmedical.com.
About MassMEDIC
The Massachusetts Medical Device Industry Council (MassMEDIC) was established in 1996 by medical device company executives interested in promoting the unique interests of the Bay State’s vibrant medical technology sector. MassMEDIC now has over 300 members -- manufacturers, product developers, suppliers, research institutions and academic health centers. The Council advocates industry positions at the federal and state government levels, and conducts numerous informational seminars, conferences and issue briefings aimed at bringing the region’s medical device community the latest and best information on policies and trends impacting the sector.
Contact: John E. Ahern President and Chief Executive Officer NMT Medical, Inc. (617) 737-0930 jea@nmtmedical.com
NMT Medical, Inc.
CONTACT: John E. Ahern, President and Chief Executive Officer of NMTMedical, Inc., +1-617-737-0930, jea@nmtmedical.com
